Paris, France

Michel Gubelmann-Bonneau

This inventor holds 1 USPTO granted patent. Top assignee: Rhodia S.a.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Gubelmann-Bonneau. Retrieved from https://idiyas.com/inventor/michel-gubelmann-bonneau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Gubelmann-Bonneau: Innovator in Acetic Acid Production

Introduction

Michel Gubelmann-Bonneau is a notable inventor based in Paris, France. He has made significant contributions to the field of chemical engineering, particularly in the production of acetic acid. His innovative approach has garnered attention in the industry.

Latest Patents

Michel holds a patent for a process for the production of acetic acid by controlled oxidation. This process involves the reaction of ethanol with a source of oxygen, performed in the presence of a catalyst that includes vanadium, titanium, and oxygen. This method enhances the efficiency of acetic acid production, showcasing his inventive capabilities.

Career Highlights

Michel Gubelmann-Bonneau is associated with Rhodia S.A., a company known for its expertise in specialty chemicals. His work at Rhodia has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in chemical processes.

Conclusion

Michel Gubelmann-Bonneau is a prominent figure in the field of chemical engineering, with a focus on acetic acid production. His patent reflects his innovative spirit and commitment to improving industrial processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…